Missing Data Lead FDA Panel to Vote Against Rivaroxaban for ACSMissing Data Lead FDA Panel to Vote Against Rivaroxaban for ACS
FDA's Cardiovascular and Renal Drugs Advisory Committee narrowly voted against approval of the Xa inhibitor rivaroxaban for this indication at its May 23 meeting. Heartwire (Source: Medscape Today Headlines)

Montgomery County wellness calendar, May 24-31
“Issues with Alzheimer’s” Third in a series of lectures on cognitive memory disorders. Sponsored by the Alzheimer’s Association. Thursday, 1-3 p.m. Margaret Schweinhaut Senior Center, 1000 Forest Glen Rd., Silver Spring. 240-777-8086. Free. Registration required. Read full article gt;gt; (Source: Wash Post Health)